The hematologist at the University of Navarra discussed updated data from the phase KarMMa-3 trial.
Paula Rodríguez Otero, MD, PhD
Advertisement
Articles by Paula Rodríguez Otero, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
BLA for Rocket’s LAD-I Gene Therapy Under Review by FDA Again
2
Myrtelle’s Canavan Disease Gene Therapy Effects Significant Decrease in CSF NAA and Increases in Brain Myelin Volume
3
Regeneron’s Gene Therapy DB-OTO Improves Speech Perception in Children With Otoferlin-Related Hearing Loss
4
